Sonoma Pharmaceuticals, Inc. announced that in connection with the Woodstock office closure, Mr. Jerry Dvonch resigned as Chief Financial Officer. Mr. Dvonch has agreed to assist with transitioning the Company's operations to the Boulder office on or before December 31, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3599 USD | +29.18% |
|
+69.60% | +99.50% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+99.50% | 6.84M | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B | |
-2.57% | 159B |
- Stock Market
- Equities
- SNOA Stock
- News Sonoma Pharmaceuticals, Inc.
- Sonoma Pharmaceuticals, Inc. Announces Resignation of Jerry Dvonch as Chief Financial Officer